Eczema clinical trials in Texas
11 studies for Eczema are looking for participants at sites in Texas.
Cities in Texas
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
- Derm Texas, Dallas
- Stryde Research-Epiphany Dermatology, Southlake
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Nov 12, 2026 · NCT07765888Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
- DCOL Center for Clinical Research, Longview
- Harrison Dermatology, Missouri City
RecruitingObservational study
Ages 12 to 89 · All sexes · Updated Nov 9, 2026 · NCT07645820First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
- Texas Dermatology and Laser Specialists, San Antonio
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Nov 6, 2026 · NCT07527923A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
- Arlington Research Center, Arlington
- Dermatology Treatment and Research Center, Dallas
- Derm Texas, Dallas
- and 2 more
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Nov 6, 2026 · NCT07783425A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- Texas Dermatology and Laser Specialists, San Antonio
RecruitingPhase 3
Ages 2 to 11 · All sexes · Updated Nov 5, 2026 · NCT06807281Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
- Clinical Site 102, College Station
- Clinical Site 104, San Antonio
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Oct 23, 2026 · NCT07453602Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Novartis Investigative Site, Arlington
- Novartis Investigative Site, Cypress
- Novartis Investigative Site, Dallas
- and 2 more
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Sep 28, 2026 · NCT06947993A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)
- ALS Global, Irving
RecruitingPhase 2/3
Ages 18 to 80 · All sexes · Updated Sep 4, 2026 · NCT07355075A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Progressive Clinical Research, PA, San Antonio
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Aug 28, 2026 · NCT07599813A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 8, Southlake
RecruitingPhase 2
Ages 18 to 74 · All sexes · Updated Aug 12, 2026 · NCT07037901Flourish: Exploring the Early Infant Gut Microbiome
- Seeding Labs INC, Austin
RecruitingHealthy volunteers welcome
0 Months – 3 Months · All sexes · Updated Feb 24, 2026 · NCT07333482From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.